Product Images Pazopanib

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Pazopanib NDC 60505-4779 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure1.jpg - Figure1

figure1.jpg - Figure1

figure2.jpg - Figure2

figure2.jpg - Figure2

The text provides information about a treatment called Pazopanib and its effectiveness in terms of progression-free survival. The results suggest that patients taking Pazopanib experienced a median progression-free survival of 4.6 months, whereas those in the placebo group had a median progression-free survival of 1.6 months. The hazard ratio for Pazopanib compared to placebo was 0.35, indicating a significant difference in favor of Pazopanib. The results were statistically significant with a p-value of <0.001.*

bottlelabel120.jpg - bottlelabel120

bottlelabel120.jpg - bottlelabel120

Each film coated tablet contains 216.7 mg of pazopanib hydrochloride, equivalent to 200 mg of pazopanib free base. The tablets should be stored at temperatures between 20°C and 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The seal on the bottle should not be broken or missing before use. The dosage information can be found in the accompanying prescribing information. The tablets are manufactured by Apotecinc and distributed by Apotex Corp. in Weston, Florida. Pharmacists should dispense the medication along with the Medication Guide, available at www1.apotex.com/products/us.*

bottlelabel500.jpg - bottlelabel500

bottlelabel500.jpg - bottlelabel500

Each film coated tablet contains 216.7 mg of pazopanib hydrochloride, equivalent to 200 mg of pazopanib free base. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The seal on the bottle should not be broken or missing. The dosage information can be found in the accompanying prescribing information. This product is in the form of 500 tablets. The product is manufactured by Apota Inc. in Toronto, Canada and is distributed by Apotex Corp. in Weston, Florida. The pharmacist should dispense this product with the medication guide, which is available at www1.apotex.com/products/us.*

structuure.jpg - structure

structuure.jpg - structure

HCI stands for Human-Computer Interaction. It is a field of study that focuses on how people interact with computer systems and technologies. HCI involves the design, implementation, and evaluation of user interfaces to facilitate effective and efficient interaction between humans and machines. Researchers and practitioners in HCI aim to improve the usability, accessibility, and overall user experience of computer systems. They study factors such as user behavior, cognitive processes, and social interactions to understand how to design interfaces that are intuitive, user-friendly, and adaptable to different contexts. HCI plays a crucial role in the development of user-centered designs and technologies that meet the needs and preferences of diverse users.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.